June 12, 2025PFIZER INC. Hits Price Target Forecast with 7.16% Profit ~2 min.On May 28, 2025, QuantWave, an automated forecasting platform, released a long signal for PFIZER INC. stock when it was trading at $23.18....
June 11, 2025PFIZER INC. Hits Price Target Forecast with 6.25% Profit, Validating QuantWave's Analytics ~1 min.PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....
June 10, 2025PFIZER INC. Hits Price Target Forecast with 5.47% Profit - QuantWave Prediction Success ~1 min.On May 22, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) at a price of 23.04 $....
June 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments ~1 min.Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
April 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis ~1 min.PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
December 2, 2024AbbVie Inc. ABBV: Leading Pharmaceutical Company Set to Present at Citi's Global Healthcare Conference ~1 min.AbbVie Inc., a renowned pharmaceutical company, is gearing up to make a significant appearance at Citis 2024 Global Healthcare Conference....
November 20, 2024Pfizer Inc. Highlights Strategic Vision at London Healthcare Conference ~1 min.Pfizer Inc., a leading pharmaceutical company, is set to present its strategic vision at the upcoming Jefferies London Healthcare Conference....
January 9, 2025Eli Lilly and Company LLY Announces Participation in J.P. Morgan Healthcare Conference ~1 min.Eli Lilly and Company, a global pharmaceutical corporation, has recently confirmed their participation in the upcoming J.P. Morgan Healthcare Conference....
January 1, 2025Regeneron Pharmaceuticals Inc. Shows Impressive 89% Return for Investors ~1 min.Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making significant strides in the pharmaceutical industry, resulting in a decent 89% return for its investors over the last five years....
February 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024 ~2 min.Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....
